Literature DB >> 3138240

A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor.

S Lund-Katz1, J A Ibdah, J Y Letizia, M T Thomas, M C Phillips.   

Abstract

NMR spectroscopy of 13C-labeled human low density lipoprotein (LDL) has been employed to characterize the lysine (Lys) residues in apo B-100. Reductive methylation with [13C]formaldehyde converts up to two-thirds of the Lys to the dimethylamino derivative; this pool of Lys is exposed at the surface of the LDL particle. The [13C]dimethyl-Lys which are visualized exhibit resonances at chemical shifts of 42.8 and 43.2 ppm (pH 7.6) indicating that they exist in two different microenvironments; this is a reflection of the native conformation of apo B associated with lipid, because the labeled, reduced, and alkylated protein gives a single resonance when dissolved in 7 M guanidine hydrochloride. The pH dependences of the Lys chemical shifts indicate that the two types of Lys titrate with different pK values; "active" Lys have a pK of 8.9, while "normal" Lys have a pK of 10.5. About 53 active Lys and 172 normal Lys are exposed on the surface of LDL with the remaining 132 Lys which are present in the human apo B-100 molecule being buried and unavailable for methylation. Addition of paramagnetic ions indicates that the active and normal Lys have different exposures to the aqueous phase; apparently this is a reflection of folding of the apo B molecule. The relative involvement of active and normal Lys in binding of apo B-100 to the LDL receptor on fibroblasts was explored by measuring the decrease in receptor binding as a function of the degree of methylation of the two types of Lys. Upper limits of 21 active and 31 normal Lys in the entire apo B-100 molecule are involved in the binding of LDL to the receptor. It is likely that these Lys are located in domains of apo B which contain clusters of basic amino acid residues and also bind heparin. If the sequence corresponding to apo B-48 (residues 1-2151) which does not bind to the receptor is excluded, then the above limits are halved; an upper limit of 10 active Lys may be particularly involved in receptor binding.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.

Authors:  Gang Zheng; Juan Chen; Hui Li; Jerry D Glickson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

2.  Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.

Authors:  Rohit S Mulik; Hui Zheng; Kumar Pichumani; James Ratnakar; Qiu-Xing Jiang; Ian R Corbin
Journal:  Chem Phys Lipids       Date:  2017-03-22       Impact factor: 3.329

3.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Ian R Corbin; Hui Li; Juan Chen; Sissel Lund-Katz; Rong Zhou; Jerry D Glickson; Gang Zheng
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

5.  2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles.

Authors:  Francisco J Blanco; Sandra Villegas; Sònia Benítez; Cristina Bancells; Tammo Diercks; Jordi Ordóñez-Llanos; José L Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

Review 6.  Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia.

Authors:  G Rauh; C Keller; H Schuster; G Wolfram; N Zöllner
Journal:  Clin Investig       Date:  1992-01

7.  Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

Authors:  W März; M W Baumstark; H Scharnagl; V Ruzicka; S Buxbaum; J Herwig; T Pohl; A Russ; L Schaaf; A Berg
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Molecular structure of low density lipoprotein: current status and future challenges.

Authors:  Ruth Prassl; Peter Laggner
Journal:  Eur Biophys J       Date:  2008-09-17       Impact factor: 1.733

9.  Enhancing the contrast of ApoB to locate the surface components in the 3D density map of human LDL.

Authors:  Yuhang Liu; David Atkinson
Journal:  J Mol Biol       Date:  2010-10-26       Impact factor: 5.469

10.  Quantification of the accumulation and degradation of beta-very-low-density lipoproteins in vivo using a 19F-containing residualizing label and n.m.r. spectroscopy.

Authors:  L A Meeh; J J Ackerman; S R Thorpe; A Daugherty
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.